Health
Moderna shares sink over 25% as cancer vaccine data triggers ‘sell-the-news’ retreat
By Katherine Langford
Globe and Mail Business
Moderna shares sink after leaked cancer data missed expectations
Melanoma vaccine treatment cut risk of recurrence or death by 58% but failed to exceed Wall Street’s lofty expectations
Up nextModerna shares sink over 25% as cancer vaccine data triggers ‘sell-the-news’ retreatHealth · 1 min read
More Health stories
Health
Moderna’s cancer vaccine hits its targets, but a data leak rattled investors and the stock tumbled
By Marcus Chen
MarketWatch
Technology
OpenAI trims valuation target to $1.25tn after pitching higher price
By Katherine Langford
Financial Times
Business
Airfares will not return to pre-Iran war levels, American Airlines warns
By Marcus Chen
Financial Times